Growth Metrics

Edwards Lifesciences (EW) Short term Debt (2017 - 2018)

Edwards Lifesciences (EW) has 7 years of Short term Debt data on record, last reported at $599.2 million in Q2 2018.

  • For Q2 2018, Short term Debt changed N/A year-over-year to $599.2 million; the TTM value through Jun 2018 reached $599.2 million, changed N/A, while the annual FY2017 figure was $51.7 million, N/A changed from the prior year.
  • Short term Debt reached $599.2 million in Q2 2018 per EW's latest filing, roughly flat from $598.6 million in the prior quarter.
  • Across five years, Short term Debt topped out at $599.2 million in Q2 2018 and bottomed at $2.2 million in Q3 2014.
  • Average Short term Debt over 3 years is $216.0 million, with a median of $46.6 million recorded in 2017.
  • The widest YoY moves for Short term Debt: up 80.15% in 2014, down 80.15% in 2014.
  • A 3-year view of Short term Debt shows it stood at $2.6 million in 2014, then surged by 1888.46% to $51.7 million in 2017, then surged by 1058.99% to $599.2 million in 2018.
  • Per Business Quant database, its latest 3 readings for Short term Debt were $599.2 million in Q2 2018, $598.6 million in Q1 2018, and $51.7 million in Q4 2017.